These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14877801)

  • 61. Immunization of cotton rats with inactivated Lansing poliomyelitis virus. II. Inactivation by physical methods.
    DICK GW; SCHWERDT CE; HUBER W; SHARPLESS GR; HOWE HA
    Am J Hyg; 1951 Mar; 53(2):131-8. PubMed ID: 14819000
    [No Abstract]   [Full Text] [Related]  

  • 62. Plaque formation with poliomyelitis, Coxsackie, and orphan (echo) viruses in bottle cultures of monkey epithelial cells.
    HSIUNG GD; MELNICK JL
    Virology; 1955 Dec; 1(5):533-5. PubMed ID: 13274749
    [No Abstract]   [Full Text] [Related]  

  • 63. Global eradication of poliomyelitis: reinvent the wheel or use existing options effectively?
    Ogra PL
    Public Health Rev; 1993-1994; 21(1-2):143-50. PubMed ID: 8041881
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Neurovirulence of attenuated type 1 poliovirus vaccine strains after intramuscular inoculation of rhesus monkeys.
    KIRSCHSTEIN R; BARON S; BORMAN GS; MURRAY R; PERKINS FT; HOTTLE G
    Virology; 1960 May; 11():300-2. PubMed ID: 14409387
    [No Abstract]   [Full Text] [Related]  

  • 65. The effect of animal viruses on host cell metabolism. II. Effect of poliomyelitis virus on glycolysis and uptake of glycine by monkey kidney tissue cultures.
    LEVY HB; BARON S
    J Infect Dis; 1957; 100(2):109-18. PubMed ID: 13416643
    [No Abstract]   [Full Text] [Related]  

  • 66. [METHODS AND RESULTS OF PREPARATION OF LIVE POLIOMYELITIS VACCINE, NOT CONTAINING MIXTURES OF VACUOLIZING VIRUS (OB40-SV40)].
    CHUMAKOV MP; DZAGUROV SG; LASHKEVICH VA; GRACHEV VP; MIRONOVA LL; RALF NM; ELBERT LB
    Vopr Virusol; 1963; 29():445-9. PubMed ID: 14071282
    [No Abstract]   [Full Text] [Related]  

  • 67. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative.
    Fine PE; Carneiro IA
    Am J Epidemiol; 1999 Nov; 150(10):1001-21. PubMed ID: 10568615
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A poliomyelitis virus pathogenic for suckling mice and monkeys.
    STANLEY NF; DORMAN DC
    Aust J Exp Biol Med Sci; 1953 Feb; 31(1):1-7. PubMed ID: 13058807
    [No Abstract]   [Full Text] [Related]  

  • 70. Immunization with oral poliovirus vaccine in China.
    Dong DX
    Rev Infect Dis; 1984; 6 Suppl 2():S431. PubMed ID: 6740087
    [TBL] [Abstract][Full Text] [Related]  

  • 71. DIFFERENTIAL SENSITIVITY OF POLIOVIRUS STRAINS TO TOLUENE.
    BALAYAN MS; PANOSYAN GA
    Acta Virol; 1965 Jan; 9():93. PubMed ID: 14299362
    [No Abstract]   [Full Text] [Related]  

  • 72. Contact transmission of poliomyelitis virus among monkeys.
    CRAIG DE; FRANCIS T
    Proc Soc Exp Biol Med; 1958 Nov; 99(2):325-9. PubMed ID: 13601859
    [No Abstract]   [Full Text] [Related]  

  • 73. Passive transfer of immunity to Lansing poliomyelitis virus from actively immunized mothers to young mice.
    THOMPSON R; MEYERS FP
    Am J Hyg; 1950 Sep; 52(2):213-21. PubMed ID: 14771043
    [No Abstract]   [Full Text] [Related]  

  • 74. Antiviral effect of guanidine.
    RIGHTSEL WA; DICE JR; McALPINE RJ; TIMM EA; McLEAN IW; DIXON GJ; SCHABEL FM
    Science; 1961 Aug; 134(3478):558-9. PubMed ID: 13741634
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Serum inhibition of cytopathic effect and virus release of type 3 poliovirus vaccine in primary monkey-kidney (MK) cultures.
    ORSI EV; MESSORE G; LEVINE S; ROCA-GARCIA M
    Am J Hyg; 1961 May; 73():282-93. PubMed ID: 13731294
    [No Abstract]   [Full Text] [Related]  

  • 76. Immunological strain specificity within type 1 poliovirus.
    GARD S
    Bull World Health Organ; 1960; 22(3-4):235-42. PubMed ID: 13826481
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis.
    Khetsuriani N; Prevots DR; Quick L; Elder ME; Pallansch M; Kew O; Sutter RW
    J Infect Dis; 2003 Dec; 188(12):1845-52. PubMed ID: 14673763
    [TBL] [Abstract][Full Text] [Related]  

  • 78. THE COMPLEMENT FIXATION REACTION FOR MEASUREMENT OF IMMUNOGENIC ANTIGENS IN FORMALDEHYDE-INACTIVATED POLIOMYELITIS VACCINE.
    MACMORINE HG; WARDLAW AC; WEBER JC
    J Immunol; 1965 Apr; 94():611-21. PubMed ID: 14299037
    [No Abstract]   [Full Text] [Related]  

  • 79. THE BEHAVIOUR OF ATTENUATED STRAINS OF POLIOVIRUS IN MONKEYS.
    BESWICK TS; COID CR; HARTLEY E; HENDERSON M; WINTER M
    J Neurol Neurosurg Psychiatry; 1964 Feb; 27(1):10-24. PubMed ID: 14123918
    [No Abstract]   [Full Text] [Related]  

  • 80. The virulence of strains of poliovirus for cynomologus monkeys after subcutaneous injection.
    COID CR; BESWICK TS; TOBIN JO
    J Hyg (Lond); 1961 Dec; 59(4):387-94. PubMed ID: 13880383
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.